Citizens National Bank Trust Department Amgen Inc Transaction History

Citizens National Bank Trust Department

$471 Million
Q4 2024

A detailed history of Citizens National Bank Trust Department transactions in Amgen Inc stock. As of the latest transaction made, Citizens National Bank Trust Department holds 9,344 shares of AMGN stock, worth $2.88 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

9,344

Previous 9,754 4.2%

Holding current value

$2.88 Million

Previous $3.14 Million 22.5%

% of portfolio

0.52%

Previous 0.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$258.78 - $328.31 $106,099 - $134,607	-410 Reduced 4.2%	9,344 $2.44 Million
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $29,391 - $32,051	-95 Reduced 0.96%	9,754 $3.14 Million
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $53,863 - $65,458	-205 Reduced 2.04%	9,849 $3.08 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $27,693 - $33,429	-103 Reduced 1.01%	10,054 $2.86 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $12,785 - $14,422	-50 Reduced 0.49%	10,157 $2.93 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $48,758 - $60,535	-223 Reduced 2.14%	10,207 $2.74 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $60,424 - $71,450	-282 Reduced 2.63%	10,430 $2.32 Million
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $49,673 - $60,544	-220 Reduced 2.01%	10,712 $2.59 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $22,903 - $29,101	-100 Reduced 0.91%	10,932 $2.87 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $26,935 - $30,378	120 Added 1.1%	11,032 $2.49 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $609,074 - $677,793	2,640 Added 31.91%	10,912 $2.66 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $74,551 - $82,473	340 Added 4.29%	8,272 $1.93 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $486,858 - $557,164	-2,448 Reduced 23.58%	7,932 $1.78 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $30,779 - $36,061	-145 Reduced 1.38%	10,380 $2.21 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $5,605 - $6,219	-24 Reduced 0.23%	10,525 $2.57 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 1.17%	10,549 $2.62 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $23,801 - $28,343	110 Added 1.04%	10,674 $2.45 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $258,115 - $287,045	1,100 Added 11.62%	10,564 $2.69 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $467,820 - $574,080	2,365 Added 33.31%	9,464 $2.23 Million
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $1.29 Million - $1.72 Million	7,099 New	7,099 $1.44 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.

Account

Citizens National Bank Trust Department Amgen Inc Transaction History